Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre

SIMPLE SUMMARY: The effectiveness and safety of immune checkpoint inhibitors in the treatment of patients with advanced cutaneous squamous cell carcinoma were evaluated in a real-world population, including patients who would have typically been excluded from clinical trials. We identified 36 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch Hein, Erica C., Vilbert, Maysa, Hirsch, Ian, Fernando Ribeiro, Mauricio, Muniz, Thiago P., Fournier, Cynthia, Abdulalem, Khaled, Saldanha, Erick F., Martinez, Erika, Spreafico, Anna, Hogg, David H., Butler, Marcus O., Saibil, Samuel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487051/
https://www.ncbi.nlm.nih.gov/pubmed/37686588
http://dx.doi.org/10.3390/cancers15174312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487051/
https://www.ncbi.nlm.nih.gov/pubmed/37686588
http://dx.doi.org/10.3390/cancers15174312

Ejemplares similares